A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
| Autor: | Zhang, L. *, Lu, S., Feng, J., Dechaphunkul, A., Chang, J., Wang, D., Chessari, S., Lanzarotti, C., Jordan, K., Aapro, M. |
|---|---|
| Zdroj: | In Annals of Oncology February 2018 29(2):452-458 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|